Post by Hologic, Inc.

For many breast cancer survivors, treatment doesn’t end after surgery, chemotherapy or radiation. Ongoing therapy often includes medications designed to block the production of hormones that can fuel cancer growth. But these types of drugs can come with significant side effects. That makes one question especially important: how long should treatment continue? In our latest story, we talk to Hologic Associate Medical Director Dr. Sami Diab and Duke Cancer Institute nurse practitioner Kassiane Saieed about how personalized tools like the Breast Cancer Index Test help them and their patients move beyond a one-size-fits-all approach to survivorship care.* Read the article: https://ow.ly/1psZ50Z9S0L #NationalCancerSurvivorsMonth #WomensHealth *Sami Diab, MD is the Associate Medical Director of Biotheranostics, Inc., A Hologic Company. Kassiane Saieed, DNP, AGNP-C is a consultant of Biotheranostics, Inc., A Hologic Company. Statements reflect their own personal views and interpretations.